Luy Ing Yan

Director/Board Member at MICROPORT CARDIOFLOW MEDTECH CORPORATION

Net worth: 83 183 $ as of 31/03/2024

43 year

Health Technology

Consumer Services

Profile

Luy Ing Yan is currently an Executive Director at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and an Executive Director & VP-Regulatory Affairs at MicroPort CardioFlow Medtech Corp.
She completed her undergraduate and graduate degrees at Capital Medical University in 2004 and 2012, respectively.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MICROPORT CARDIOFLOW MEDTECH CORPORATION 0.02%	11/07/2023	576,137 ( 0.02% )	83 183 $	31/03/2024

Luy Ing Yan active positions

Companies	Position	Start
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Director/Board Member	29/09/2020
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Director/Board Member	29/09/2020

All active positions of Luy Ing Yan

Training of Luy Ing Yan

Capital Medical University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Luy Ing Yan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
MICROPORT CARDIOFLOW MEDTECH CORPORATION	Health Technology

Private companies	1
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023.	Health Technology